Pages
Join the bank
DCHS employs temporary staff via our bank or from agencies. The temporary staffing team support this activity, including Covid-19 temporary staffing.
Continence services
https://dchs.nhs.uk/our-services-and-locations/a-z-list-of-services/adult-services
Turf cutting marks the start on site for £10.5 million new health hub in Bakewell
https://dchs.nhs.uk/news/turf-cutting-marks-start-site-105-million-new-health-hub-bakewell
Finance and Procurement System Changes
The Trust’s current contract for the provision of financial services (i.e. finance and procurement) from NHS Shared Business Services (SBS) is coming to an end on 31 March 2022.
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/finance-and-procurement-system-changes
Files
DCHS Tissue Viability Non-Concordance guidelines and Pathway (G309)
DCHS Tissue Viability Non-Concordance guidelines and Pathway
ICS Catheter Clinic Guidance (G324)
ICS Catheter Clinic Guidance
Policy template FINAL (DCHS Policy Development Framework)
Policy template FINAL (DCHS Policy Development Framework)
Disclosure Ref 2024135 - No. of Datix Incidents Involving Patient Misidentification.pdf
FOI Disclosure Ref 2024135 regarding number of Datix Incidents Involving Patient Misidentification
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times
Integrated Performance Report - November 2024
Integrated Performance Report - November 2024
8 Steps to Patient Isolation (L343)
Guidance to support colleagues when deciding how to isolate a patient with suspected/confirmed infection.